SCHEMBL10238656

SCHEMBL10238656

O=S(=O)(Nc1ccc2c(c1)CNCC2)c1ccc2c(c1)CCCO2

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNMT P11086 4/20 0.61
TRIM24 O15164 1/20 0.60
BRD1 O95696 1/20 0.60
BRPF1 P55201 1/20 0.60
PKLR P30613 1/20 0.55
HTR2C P28335 2/20 0.54
HTR6 P50406 2/20 0.54
DRD2 P14416 1/20 0.54
HTR2A P28223 1/20 0.54
DRD3 P35462 1/20 0.54
PKM P14618 4/20 0.54
MAPT P10636 1/20 0.54
HTR2B P41595 1/20 0.51
BRD4 O60885 2/20 0.48
LMNA P02545 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
POLB P06746 1/20 0.47
ADRA2A P08913 1/20 0.47
ADRA2B P18089 1/20 0.47
ADRA2C P18825 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3350485 0.88 PNMT (0.54) PNMTTRIM24BRD1BRPF1PKLR
SCHEMBL13757810 0.88 PNMT (0.62) PNMTHTR2CHTR6DRD2HTR2A
Hydrochloric Acid SCHEMBL9957225 0.87 PNMT (0.61) PNMTHTR2CHTR6DRD2HTR2A
SCHEMBL3353744 0.84 PKLR (0.65) PNMTTRIM24BRD1BRPF1PKLR
SCHEMBL13757776 0.84 PNMT (0.76) PNMTHTR2CHTR6DRD2HTR2A
Hydrochloric Acid SCHEMBL9958844 0.82 PNMT (0.74) PNMTHTR2CHTR6DRD2HTR2A
SCHEMBL10239988 0.80 PKM (0.67) PNMTTRIM24BRD1BRPF1PKLR
Hydrochloric Acid SCHEMBL9957679 0.79 PKM (0.66) PNMTTRIM24BRD1BRPF1PKLR
SCHEMBL13757806 0.79 HTT (0.63) PNMTTRIM24BRD1BRPF1HTR2C
Hydrochloric Acid SCHEMBL9958694 0.78 HTT (0.62) PNMTTRIM24BRD1BRPF1HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2007729-B1 SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUNDS, THEIR PREPARATION AND USE IN MEDICAMENTS ESTEVE LABOR DR (ES) 2012-06-27 EP disclosed